drugset / Trial / NCT01161121

Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia

NCT01161121

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine if regadenoson is as safe and effective as adenosine when used in the cardiac catheterization lab during measurement of coronary flow reserve and fractional flow reserve. The study hypothesis is the assessment of Fractional Flow Reserve (FFR) in the catheterization lab can be performed with equivalent accuracy when hyperemia is induced with IV Regadenoson compared with IV Adenosine without compromising patient safety.

Timeline

Start
2010-07
Primary completion
2013-04
Completion
2013-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Adenosine Small molecule 140 ug/kg Intravenous
Subject Regadenoson Diagnostic / imaging agent 0.4 mg Intravenous